2024 Archive News

Contact Us:

General Inquiries

Press Contact:

John Dobken
+1 202.641.3013
[email protected]

News Archive

2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2017 | 2016 | 2015

BWXT Awarded Contract to Develop Pilot Plant Solution for Domestic Uranium Enrichment

August 26, 2024

BWXT Names Vittorio Puppo President of Medical Business

August 6, 2024

BWX Technologies Reports Second Quarter 2024 Results

August 5, 2024

BWXT Medical and NorthStar Medical Radioisotopes Sign Supply Agreement Supporting Actinium-225 Production

July 22, 2024

BWXT to Evaluate Locations for Building New Nuclear TRISO Fuel Production Facility to Support Advanced Reactor Deployment

July 18, 2024

BWXT Awarded Phase Two of Microreactor Evaluation Contract for State of Wyoming

June 17, 2024

BWXT-led Team Awarded $30 Billion Management and Operating Contract for National Nuclear Security Administration’s Pantex Plant

June 14, 2024

BWXT Medical Submits Drug Master File for Actinium-225 API to U.S. Food and Drug Administration

June 7, 2024

BWXT employees trained as Nuclear Ambassadors

May 28, 2024

BWX Technologies Reports First Quarter 2024 Results

May 6, 2024